Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹95 Cr₹155 Cr₹179 Cr₹174 Cr₹82 Cr

What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES is ₹95 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹95 Cr
Mar2024₹155 Cr
Mar2023₹179 Cr
Mar2022₹174 Cr
Mar2021₹82 Cr

How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹95 Cr
-38.91
Mar2024 ₹155 Cr
-13.11
Mar2023 ₹179 Cr
2.88
Mar2022 ₹174 Cr
111.41
Mar2021 ₹82 Cr -

Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,865.8 Cr 6.4% 4.2% -21.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

6.4%

4.2%

-21.7%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses